Navigation Links

Amgen's First Biosimilar Biologics License Application For ABP 501 Submitted To U.S. Food And Drug Administration

THOUSAND OAKS, Calif. , Nov. 25, 2015  Amgen (NASDAQ: AMGN ) today announced the submission of a Biologics License Application (BLA) with the United States (U.S.) Food and Drug Administration (FDA) for ABP 501, a biosimilar candidate to Humira ® (adalimumab). Amgen believes this submission is the first adalimumab biosimilar application submitted to the FDA and r... [Comments]

Effort to Prevent, Treat Newborn Drug Exposure Becomes Law

WASHINGTON , Nov. 25, 2015  The American Academy of Pediatrics (AAP), American Congress of Obstetricians and Gynecologists (ACOG), and the March of Dimes cheered today's signature into law of the bipartisan Protecting Our Infants Act of 2015 (S.799), which takes much-needed strides to reduce the number of newborns born exposed to drugs, such as opioids, and to... [Comments]

Linden Care Responds To Court Ruling

WOODBURY, N.Y. , Nov. 25, 2015  Linden Care, LLC, a retail specialty pharmacy focused on medications access and optimizing treatment outcomes for patients suffering from chronic pain, said today that it is disappointed that its request for a Temporary Restraining Order (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy Provider Agreement between the... [Comments]

AAIPharma / Cambridge Major Laboratories to Invest $15M in Additional Laboratory Capacity and Global Headquarters in Wilmington, NC

WILMINGTON, N.C. , Nov. 25, 2015 AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAIPharma/CML) announces the planned investment of at least $15.8  Million to expand its laboratories and global headquarters in Wilmington, NC . The expansion will provide additional office space and development services capacity to meet the growing demands of the pharmaceuti... [Comments]

Pope McGlamry: $11 Million Verdict in First Wright Conserve Hip Bellwether Trial

ATLANTA , Nov. 25, 2015 On Tuesday, November 24, 2015, the jury in the first federal bellwether trial against Wright Medical Technology, Inc. for product liability and misrepresentation claims relating to their Conserve metal-on-metal hip implant device, awarded $11 million in favor of Plaintiff Robyn Christiansen.  Following a two week trial and three days of deliberatio... [Comments]

Accuracy of ARKRAY Blood Glucose Meters and Test Strips Demonstrated in Studies Presented at World Diabetes Congress

MINNEAPOLIS , Nov. 25, 2015  ARKRAY USA , Inc., a leader in diabetes care products, continues to provide evidence demonstrating the accuracy of its blood glucose meter systems. Last week at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease in Los Angeles , studies showed that both the Company's GLUCOCARD ® 01 meter and the Assure ... [Comments]

Henry Schein ConnectDental Pavilion At Greater New York Dental Meeting: The Next Step In Digital Dentistry

MELVILLE, N.Y. , Nov. 25, 2015  Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, will unveil at the Greater New York Dental (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion , which brings together for the first time the industry's broadest array of open solut... [Comments]

Kitov Pharmaceuticals Holdings Announces Closing of U.S. Initial Public Offering

TEL AVIV, Israel , November 25, 2015 Kitov Pharma ceuticals Holdings Ltd. (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company focused on the development of therapeutic candidates for the simultaneous treatment of various clinical conditions, today announced the closing of its previously announced underwritten public offering of 3,158,900 American Depository Shares (... [Comments]

Allergan Reaches Settlement with New York Attorney General's Office in Memantine Immediate Release Litigation

DUBLIN , Nov. 25, 2015 Allergan plc (NYSE: AGN ) today announced that it has reached an agreement with the New York State Attorney General's Office to end the litigation under Section 2 of the Sherman Act, and other statutes with the Attorney General over the decision of Forest Laboratories, Inc., announced in February 2014, to cease marketing and selling the now generic... [Comments]

Trovagene to Present at 27th Annual Piper Jaffray Healthcare Conference and Attend Evercore ISI Investor Conference

SAN DIEGO , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: TROV ), a developer of cell-free molecular diagnostics, today announced that Chief Executive Officer Antonius Schuh, Ph.D., is scheduled to present a corporate overview at the 27 th Annual Piper Jaffray Healthcare Conference. th Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York o... [Comments]

[previous] [next]
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - Today, ... specializing in both surgical and non-surgical treatments, announced the expansion of his private ... Plastic Surgery. , Highly trained and nationally recognized for his natural approach, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... provide scholarships for people struggling with eating disorders as a result of the ... second annual event, held at Fox Run Golf Club in Eureka, will help ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... that it has undertaken significant expansion of its current state of the art ... part of PharmaTech’s strategy to increase its manufacturing capacity as well as to ...
Breaking Medicine News(10 mins):
... VISIPAQUE is the only isosmolar contrast medium (IOCM™) ... to that of blood, VISIPAQUE was designed for ... only contrast medium formulated with sodium and calcium ... VISIPAQUE received FDA approval for use in children ...
The Mitek Restore System, designed in conjunction with Sanford S. Kunkel, M.D., offers instrumentation for all ACL Procedures....
The Pinn-ACL Guide can be used to create tibial tunnels of known lengths with a variable angle adjustment of 35 to 60 degrees with the use of a,graduated pin-sleeve....
... This small dermatome can cut a 42 mm ... facilitates cutting of the 42x42 mm graft required ... tool in paediatric and general plastic surgery, especially ... surfaces. For the same dermatome also a wider ...
Medicine Products:
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma Services ... investment of at least $15.8  Million to expand ... Wilmington, NC . The expansion will provide ... meet the growing demands of the pharmaceutical and ... site expansion will provide up to 40,000 square ...
(Date:11/25/2015)...  Henry Schein, Inc., the world,s largest provider of ... and animal health practitioners, will unveil at the Greater ... ConnectDental® Pavilion , which brings together for the first ... to help any practice or laboratory enter the digital ... schedule of experts appearing at the Pavilion. --> ...
Breaking Medicine Technology: